Main
>
ONCOLOGY (**)
>
Leukemia>Lymphocytic>Chronic ***
>
Treatment
>
USA. A. Venetoclax+ObinutuzuMAb
>
(*) USA Approval Date: 2019. 05.15
(*) USA Approval Date: 2019. 05.15's products
This section has no products